Histide's Private Equity Round

Histide raised a round of funding on November 10, 2014. Investors include PARTER Capital Group.

Histide is pioneering Recoding Therapeutics, a novel therapy using non-mutagenic extracellular technologies to direct cell fate. Based on the universal understanding of the mechanisms underlying mamma…

Articles about Histide's Private Equity Round: